NeoGenomics, Inc. (NEO): $49.34

-0.20 (-0.40%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Neogenomics Inc (NEO) Price Targets From Analysts

Use the tables below to see what analysts covering Neogenomics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
10 $66 $60 $63.2 $48.91 29.22%

The Trend in the Analyst Price Target


NEO's average price target has moved up $21.14 over the prior 189 days.

NEO reports an average of 9.18% for its upside potential over the past 315 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-05-30 6 36.0 32.0 34.00 26.69 27.39%
2020-06-25 7 36.0 32.0 34.00 29.32 15.96%
2020-07-14 7 40.0 32.0 35.00 35.31 -0.88%
2020-07-20 7 40.5 32.0 35.93 37.14 -3.26%
2020-07-29 7 45.0 39.0 40.93 37.53 9.06%
2020-08-27 8 46.0 39.0 41.56 37.72 10.18%
2020-09-09 9 46.0 39.0 42.06 36.94 13.86%
2020-10-03 9 46.0 39.0 42.06 36.08 16.57%
2020-10-27 9 50.0 40.5 46.28 41.25 12.19%
2020-11-19 9 50.0 40.5 46.61 42.73 9.08%
2020-12-07 9 50.0 40.5 46.61 49.21 -5.28%
2020-12-09 9 50.0 40.5 46.61 49.52 -5.88%
2020-12-19 10 60.0 40.5 47.95 53.62 -10.57%
2020-12-26 10 60.0 40.5 47.95 55.40 -13.45%
2021-01-02 10 60.0 40.5 47.95 53.84 -10.94%
2021-01-09 10 62.0 46.0 52.50 52.44 0.11%
2021-01-16 10 62.0 46.0 52.50 52.78 -0.53%
2021-01-23 10 62.0 46.0 52.50 56.03 -6.3%
2021-01-30 11 70.0 46.0 55.82 53.02 5.28%
2021-02-06 11 70.0 46.0 57.27 55.00 4.13%
2021-02-13 11 70.0 46.0 57.27 59.88 -4.36%
2021-02-20 11 70.0 46.0 57.27 56.56 1.26%
2021-02-27 10 70.0 60.0 64.60 50.97 26.74%
2021-03-06 10 70.0 60.0 64.60 43.25 49.36%
2021-03-13 10 66.0 60.0 63.60 49.23 29.19%
2021-03-20 10 66.0 60.0 63.60 50.18 26.74%
2021-04-03 10 66.0 60.0 63.20 48.53 30.23%
2021-04-10 10 66.0 60.0 63.20 48.17 31.2%

NEO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.29 6 5 1 0 0 12

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Neogenomics Inc's variance in analysts' estimates is less than 88.06% of stocks in the mid market cap category.
  • The number of analysts covering the stock of NEO is greater than 82.59% of Healthcare stocks.
  • NEO has a higher upside potential (average analyst target price relative to current price) than 79.41% of stocks in the mid market cap category.
  • Neogenomics Inc's average analyst price target is higher than 78.14% of Healthcare stocks.

In the Business Services industry, ACCD, WSC and SPT are the three stocks most similar to Neogenomics Inc regarding the price target and analyst recommendation information presented here.

Is NEO a Buy, Hold or Sell? See the POWR Ratings now!



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8649 seconds.